{"id":"https://openalex.org/W2007640132","doi":"https://doi.org/10.1007/s00280-005-0116-2","title":"Pegylated liposomal doxorubicin in combination with gemcitabine: a phase II study in anthracycline-na\u00efve and anthracycline pretreated metastatic breast cancer patients","display_name":"Pegylated liposomal doxorubicin in combination with gemcitabine: a phase II study in anthracycline-na\u00efve and anthracycline pretreated metastatic breast cancer patients","publication_year":2005,"publication_date":"2005-09-14","ids":{"openalex":"https://openalex.org/W2007640132","doi":"https://doi.org/10.1007/s00280-005-0116-2","mag":"2007640132","pmid":"https://pubmed.ncbi.nlm.nih.gov/16163541"},"language":"en","primary_location":{"id":"doi:10.1007/s00280-005-0116-2","doi":"https://doi.org/10.1007/s00280-005-0116-2","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00280-005-0116-2","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045496715","display_name":"Alessandra Fabi","orcid":"https://orcid.org/0000-0002-0758-8033","observed_orcids":["https://orcid.org/0000-0002-0758-8033"]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Alessandra Fabi","raw_affiliation_strings":["Division of Medical Oncology \"A\", Regina Elena Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy. alessandra.fabi@virgilio.it","Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology \"A\", Regina Elena Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy. alessandra.fabi@virgilio.it","institution_ids":["https://openalex.org/I4387152244"]},{"raw_affiliation_string":"Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061240925","display_name":"Gianluigi Ferretti","orcid":"https://orcid.org/0000-0002-2271-6427","observed_orcids":["https://orcid.org/0000-0002-2271-6427"]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gianluigi Ferretti","raw_affiliation_strings":["Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy","Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]},{"raw_affiliation_string":"Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086199413","display_name":"Paola Papaldo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Paola Papaldo","raw_affiliation_strings":["Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy","Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]},{"raw_affiliation_string":"Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045815813","display_name":"Nello Salesi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Nello Salesi","raw_affiliation_strings":["Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy","Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]},{"raw_affiliation_string":"Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102966394","display_name":"Mariangela Ciccarese","orcid":"https://orcid.org/0000-0002-0273-5209","observed_orcids":["https://orcid.org/0000-0002-0273-5209"]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mariangela Ciccarese","raw_affiliation_strings":["Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy","Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]},{"raw_affiliation_string":"Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102015653","display_name":"Vito Lorusso","orcid":"https://orcid.org/0000-0003-0670-7747","observed_orcids":["https://orcid.org/0000-0003-0670-7747"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vito Lorusso","raw_affiliation_strings":["Division of Medical Oncology, National Cancer Institute, Bari, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, National Cancer Institute, Bari, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020732852","display_name":"Paolo Carlini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Paolo Carlini","raw_affiliation_strings":["Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy","Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]},{"raw_affiliation_string":"Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062971539","display_name":"Armando Carpino","orcid":"https://orcid.org/0000-0001-8557-2304","observed_orcids":["https://orcid.org/0000-0001-8557-2304"]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Armando Carpino","raw_affiliation_strings":["Cardiology Unit, Regina Elena Cancer Institute, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiology Unit, Regina Elena Cancer Institute, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023710153","display_name":"Marcella Mottolese","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marcella Mottolese","raw_affiliation_strings":["Department of Pathology, Regina Elena Cancer Institute, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Regina Elena Cancer Institute, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010507443","display_name":"Anna Maria Cianciulli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Maria Cianciulli","raw_affiliation_strings":["Department of Clinical Pathology, Cytogenetic Unit, Rome, Italy","Cytogenetic Unit"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pathology, Cytogenetic Unit, Rome, Italy","institution_ids":[]},{"raw_affiliation_string":"Cytogenetic Unit","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086743021","display_name":"Diana Giannarelli","orcid":"https://orcid.org/0000-0002-6085-1195","observed_orcids":["https://orcid.org/0000-0002-6085-1195"]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Diana Giannarelli","raw_affiliation_strings":["Biostatistics Unit, Regina Elena Cancer Institute, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistics Unit, Regina Elena Cancer Institute, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068721926","display_name":"Isabella Sperduti","orcid":"https://orcid.org/0000-0001-5115-3099","observed_orcids":["https://orcid.org/0000-0001-5115-3099"]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Isabella Sperduti","raw_affiliation_strings":["Biostatistics Unit, Regina Elena Cancer Institute, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistics Unit, Regina Elena Cancer Institute, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042436465","display_name":"Alessandra Felici","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alessandra Felici","raw_affiliation_strings":["Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy","Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]},{"raw_affiliation_string":"Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101951892","display_name":"Francesco Cognetti","orcid":"https://orcid.org/0000-0001-8498-151X","observed_orcids":["https://orcid.org/0000-0001-8498-151X"]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesco Cognetti","raw_affiliation_strings":["Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy","Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]},{"raw_affiliation_string":"Division of Medical Oncology \u201cA\u201d, Regina Elena Cancer Institute, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5045496715"],"corresponding_institution_ids":["https://openalex.org/I4387152244"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":1.0426,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.7661926,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"57","issue":"5","first_page":"615","last_page":"623"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.5224999785423279,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.5224999785423279,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.448199987411499,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.007400000002235174,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pegylated-liposomal-doxorubicin","display_name":"pegylated liposomal doxorubicin","score":1.0},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":1.0},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9620000123977661},{"id":"https://openalex.org/keywords/anthracycline-pretreated-patients","display_name":"anthracycline-pretreated patients","score":0.9449999928474426},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.9010000228881836},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.6259999871253967},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.824999988079071},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9739999771118164},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.7590000033378601},{"id":"https://openalex.org/keywords/left-ventricular-ejection-fraction","display_name":"left ventricular ejection fraction","score":0.8799999952316284},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.5049999952316284}],"concepts":[{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.9258736968040466},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.828197717666626},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.8017736673355103},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6773523092269897},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5991567373275757},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5306485891342163},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4718967378139496},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4594065248966217},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.45345398783683777},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.44024622440338135},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.43127283453941345},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39123740792274475}],"mesh":[{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018943","descriptor_name":"Anthracyclines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s00280-005-0116-2","doi":"https://doi.org/10.1007/s00280-005-0116-2","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00280-005-0116-2","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:16163541","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16163541","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer chemotherapy and pharmacology","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W1505216143","https://openalex.org/W1804680040","https://openalex.org/W1812067939","https://openalex.org/W1936102867","https://openalex.org/W1972536070","https://openalex.org/W1973295231","https://openalex.org/W1976052438","https://openalex.org/W1991211039","https://openalex.org/W1993149809","https://openalex.org/W1997838307","https://openalex.org/W2006632178","https://openalex.org/W2029458457","https://openalex.org/W2035332337","https://openalex.org/W2050466428","https://openalex.org/W2096593771","https://openalex.org/W2098927273","https://openalex.org/W2104095433","https://openalex.org/W2104337757","https://openalex.org/W2120757369","https://openalex.org/W2120849258","https://openalex.org/W2121794314","https://openalex.org/W2128684923","https://openalex.org/W2148845753","https://openalex.org/W2157470118","https://openalex.org/W2164789874","https://openalex.org/W2167805334","https://openalex.org/W2169253572","https://openalex.org/W2235063564","https://openalex.org/W2256907576","https://openalex.org/W2295658630","https://openalex.org/W2328452031","https://openalex.org/W2408994916","https://openalex.org/W2596075194","https://openalex.org/W2596486877","https://openalex.org/W3027693442"],"related_works":["https://openalex.org/W2780664801","https://openalex.org/W1991211039","https://openalex.org/W2267994711","https://openalex.org/W2242645141","https://openalex.org/W2038171956","https://openalex.org/W2012378164","https://openalex.org/W2590530082","https://openalex.org/W2508451725","https://openalex.org/W2089046092","https://openalex.org/W2532290530"],"abstract_inverted_index":null,"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}